Improving Mothers' Own Milk Provision at NICU Discharge: Optimizing Achievement of Secretory Activation and Coming to Volume as Key Strategies

Webinar • Medela Ag

About the CPD course

Embedded in this approach is evidence that the mammary gland undergoes essential programming during the first two weeks postpartum; which can be measured with biomarkers; and is essential to long-term mothers' own milk (MOM) provision. Clinical strategies that target the early postpartum period will be highlighted; including species-specific mammary gland stimulation; monitoring of MOM biomarkers of secretory activation and assessment of coming to volume. Additionally; the distinction between impaired secretory differentiation and delayed/impaired secretory activation in this population will be discussed; with application to NICU mothers who have multiple inflammation-based morbidities that increase the risk for lactation problems.

CPD Provider

Medela Ag

View Profile

Send an enquiry

Full Name*

Email Address*

Contact Number*

Industry*

Your Enquiry*

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Medela Ag

Medela Healthcare is a global manufacturer of medical vacuum solutions that are respected and trusted by doctors and healthcare professionals from around the world. Medela Healthcare seeks to improve the lives of patients, doctors and hospital staff through constant innovation and our passion to understand the challenges that patients and clinicians face in their daily lives. Life is precious and needs passionate people - like those at Medela - to provide progressive care.